Journal article
Periprocedural Myocardial Infarction: Review and Classification
Clinical cardiology (Mahwah, N.J.), Vol.33(8), pp.476-483
08/01/2010
DOI: 10.1002/clc.20819
PMCID: PMC6653301
PMID: 20734444
Abstract
Technical and pharmacologic advances have reduced the occurrence of large periprocedural myocardial infarction (PMI) after percutaneous coronary interventions (PCI), but PMI still occurs in 6% to 18% of the cases and is associated with impaired short- and long-term survival. PMI might be due to side branch closure or flow-limiting dissection, but is most often diagnosed after apparently uncomplicated PCI and is due to atheroembolization into the microcirculation. Various definitions of PMI are used in clinical trials, but a rise in creatine kinase-MB greater than 3 to 8 times the upper limit of normal is consistently associated with worse prognosis, particularly as it reflects a more extensive and unstable atherosclerotic burden. On the other hand, data regarding the independent prognostic value of periprocedural troponin increase are conflicting. Some data suggest that PM! has a better prognosis than a spontaneously occurring myocardial infarction, and that its incidence is reduced with aggressive antiplatelet and statin therapy.
Details
- Title: Subtitle
- Periprocedural Myocardial Infarction: Review and Classification
- Creators
- Elias B. Hanna - University of Oklahoma Health Sciences CenterThomas A. Hennebry - University of Oklahoma Health Sciences Center
- Resource Type
- Journal article
- Publication Details
- Clinical cardiology (Mahwah, N.J.), Vol.33(8), pp.476-483
- DOI
- 10.1002/clc.20819
- PMID
- 20734444
- PMCID
- PMC6653301
- NLM abbreviation
- Clin Cardiol
- ISSN
- 0160-9289
- eISSN
- 1932-8737
- Publisher
- Wiley
- Number of pages
- 8
- Language
- English
- Date published
- 08/01/2010
- Academic Unit
- Cardiovascular Medicine; Internal Medicine
- Record Identifier
- 9984359679302771
Metrics
8 Record Views